Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Breast cancer may be detectable through changes in scalp hair lipids.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

A group has developed therapies that show promise for treating cancer and various other conditions.

Male pattern baldness may predict prostate cancer risk.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Grape seed extract may safely and effectively help prevent lung cancer.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.